Pauriah, Maheshwar <br/><br/>
Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.  [electronic resource] 

 -  Cardiovascular therapeutics  2008 
 - 85-8 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1755-5914 
<br/><br/><label>Standard No.: </label>10.1111/j.1527-3466.2008.00048.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticholesteremic Agents--therapeutic use<br/>Azetidines--therapeutic use<br/>Biomarkers<br/>Biomarkers, Pharmacological--blood<br/>C-Reactive Protein--metabolism<br/>Carotid Arteries--drug effects<br/>Cholesterol, LDL--blood<br/>Clinical Trials as Topic<br/>Drug Combinations<br/>Ezetimibe, Simvastatin Drug Combination<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypercholesterolemia--blood<br/>Reproducibility of Results<br/>Simvastatin--therapeutic use<br/>Treatment Outcome